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Background
Catheter-based transmyocardial injection offers a mini-
mally invasive method to deliver therapeutics to the heart.
It is typically performed under X-ray fluoroscopic gui-
dance, which suffers from poor demarcation of myocardial
boundaries and an inability to assess myocardial viability.
MRI-guided intramyocardial delivery of therapeutics at 3T
offers the potential for more precise targeting of these
therapies with superior tissue contrast. Our group has
been actively involved with microencapsulated stem cell
therapy to improve cell retention and prevent stem cell
rejection. However, conventional microencapsulated stem
cell products are too large to be administered transmyo-
cardially. We demonstrate here intramyocardial injection
of a prototype single stem cell therapeutic into the
myocardium of a normal swine using real-time MR
guidance and a custom active injection catheter.
Methods
Prototype alginate microbeads (50 µm diameter)
impregnated with iron oxide (MyeOne) were produced
using a custom microfluidic device. A custom MR-
trackable, steerable intramyocardial injection catheter
(10F diameter, 135 cm long, MRI Interventions, Inc.)
with four built-in tracking coils (Figure 1a) was visua-
lized on the Interactive Front End (IFE) navigation
software (Siemens Corporate Research) in conjunction
with a real-time tip-tracking sequence (BEAT_IRTTT,
Pan.L et.al, ISMRM 2011, pp. 195). The catheter and
the real-time interface were tested in a phantom, ex vivo
pig heart, and an in vivo swine study at 3T (Siemens
TimTrio). For the in vivo study, a breath-hold, multi-
slice cine TrueFISP short-axis stack was obtained, which
was segmented and converted to a 3D model (Figure
1b) for an overlay within IFE (Figure 1c). The catheter
was navigated using real-time model guidance to target
injection sites (Figure 1d). After ensuring correct needle
placement, iron oxide-impregnated alginate microbeads
(0.02 ml/injection) were injected into the myocardium
during a FLASH real-time acquisition (Figure 1e).
Delivery success was confirmed using a breath hold,
multi-slice 2D FLASH sequence (Figure 1f,g). Relevant
imaging parameters are in the figure caption.
Results
Left ventricular catheterization and guidance to four tar-
get sites in the myocardium was achieved. Confirmation
of microbead delivery on FLASH images was possible
but difficult due to the small volume and low iron con-
centration delivered. Follow-up imaging at one week
post-delivery was unable to visualize the iron oxide-
labeled therapeutic. No adverse events from transmyo-
cardial delivery were observed.
Conclusions
A real-time interface with active catheter tip tracking
enabled successful 3T MRI-guided transmyocardial
delivery of a prototype therapeutic to the in vivo heart.
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Figure 1 (a) Needle catheter showing microcoils and extended nitinol injection needle. (b) Portions of the heart segmented on cine stack
(TR/TE=3.4/1.54 ms, voxel=1.3x1.3x5 mm-cube, FA 43 degrees) are used to build 3d model of the left, right ventricle and infarcted region.
(c) 3D model overlaid into real-time MR images is used to (d) navigate the catheter to pre-defined injection targets. Catheter model is built
from MR images of active tracking coils. (e) Injection of iron-oxide laden therapeutic into myocardium (yellow arrow) monitored under
real-time MRI. TR/TE=2.8/1.19 ms, voxel=1.9x1.9x5 mm3, FA/tracking FA =50/15 degrees, 1.5-4 frames/s. (f, g) Pre- and post-injection MRI
confirms injection of microbeads. TR /TE = 6.8/3.25 ms, FA=30 degrees, voxel =1.0×1.0×5.0 mm-cube.
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